Intake of cruciferous vegetables modifies bladder cancer survival
- PMID: 20551305
- PMCID: PMC2901397
- DOI: 10.1158/1055-9965.EPI-10-0008
Intake of cruciferous vegetables modifies bladder cancer survival
Abstract
Background: Intake of cruciferous vegetables, a rich source of dietary isothiocyanates, has been inversely associated with risk of bladder cancer. Due to the potent antiproliferative effects of dietary isothiocyanates on bladder cancer in in vitro and in vivo models, cruciferous vegetable intake may also play a role in survival among patients with bladder cancer.
Methods: Using information obtained from the Roswell Park Cancer Institute Tumor Registry, patient medical records, and routinely collected questionnaire data, we examined potential associations between intake of cruciferous vegetables and survival among bladder cancer patients. As cooking can substantially reduce or destroy isothiocyanates, consumption of raw versus cooked cruciferous vegetables was examined separately. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional hazard models.
Results: A total of 239 bladder cancer patients were included in the study. After an average of 8 years of follow-up, 179 deaths occurred, with 101 deaths attributable to bladder cancer. After adjustment for other prognostic factors, a strong and significant inverse association was observed between bladder cancer mortality and broccoli intake, in particular raw broccoli intake (> or =1 versus <1 serving per month; HR for overall death, 0.57; 95% CI, 0.39-0.83; HR for disease-specific death, 0.43; 95% CI, 0.25-0.74). There were no significant associations for total vegetables, total fruits, or other individual cruciferous vegetables.
Conclusions: Considering the strong preclinical evidence, intake of broccoli may improve bladder cancer survival.
Impact: Further prospective investigation is warranted to confirm the potential role of cruciferous vegetables in bladder cancer prognosis.
Similar articles
-
Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk.Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):938-44. doi: 10.1158/1055-9965.EPI-07-2502. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398034
-
Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort.J Natl Cancer Inst. 1999 Apr 7;91(7):605-13. doi: 10.1093/jnci/91.7.605. J Natl Cancer Inst. 1999. PMID: 10203279
-
Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2090-7. doi: 10.1158/1055-9965.EPI-08-1174. Epub 2009 Jun 23. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19549811
-
Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Nutrition and health". Cruciferous vegetable intake and the risk of human cancer: epidemiological evidence.Proc Nutr Soc. 2009 Feb;68(1):103-10. doi: 10.1017/S0029665108008884. Epub 2008 Dec 8. Proc Nutr Soc. 2009. PMID: 19061536 Review.
-
Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention.Mol Nutr Food Res. 2018 Sep;62(18):e1800079. doi: 10.1002/mnfr.201800079. Epub 2018 Aug 29. Mol Nutr Food Res. 2018. PMID: 30079608 Free PMC article. Review.
Cited by
-
Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process.JMIR Cancer. 2022 Feb 15;8(1):e32291. doi: 10.2196/32291. JMIR Cancer. 2022. PMID: 35166681 Free PMC article.
-
Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer.Am J Clin Exp Urol. 2023 Apr 15;11(2):103-120. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 37168941 Free PMC article. Review.
-
Cruciferous vegetable consumption and pancreatic cancer: A case-control study.Cancer Epidemiol. 2021 Jun;72:101924. doi: 10.1016/j.canep.2021.101924. Epub 2021 Mar 11. Cancer Epidemiol. 2021. PMID: 33714902 Free PMC article.
-
Effects of complementary and integrative medicine on cancer survivorship.Curr Oncol Rep. 2015;17(5):445. doi: 10.1007/s11912-015-0445-1. Curr Oncol Rep. 2015. PMID: 25749658 Review.
-
The Inhibitory Effect of Sulforaphane on Bladder Cancer Cell Depends on GSH Depletion-Induced by Nrf2 Translocation.Molecules. 2021 Aug 13;26(16):4919. doi: 10.3390/molecules26164919. Molecules. 2021. PMID: 34443505 Free PMC article.
References
-
- Josephson DY, Pasin E, Stein JP. Superficial bladder cancer: part 1. Update on etiology, classification and natural history. Expert review of anticancer therapy. 2006;6:1723–34. - PubMed
-
- Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. PharmacoEconomics. 2003;21:1315–30. - PubMed
-
- Patard JJ, Rodriguez A, Lobel B. The current status of intravesical therapy for superficial bladder cancer. Current opinion in urology. 2003;13:357–62. - PubMed
-
- Hendricksen K, Witjes JA. Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer. Current opinion in urology. 2007;17:352–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials